Harvard Mental Health Letter

References for "Research suggests new drug targets for depression"

Berman RM, et al. "Antidepressant Effects of Ketamine in Depressed Patients," Biological Psychiatry (Feb. 15, 2000): Vol. 47, No. 4, pp. 351–54. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10686270 Diazgranados N, et al. "A Randomized Add-On Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Bipolar Depression," Archives of General Psychiatry (Aug. 2010): Vol. 67, No. 8, pp. 793–802. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20679587 Krystal JH. "Ketamine and the Potential Role for Rapid-Acting Antidepressant Medications," Swiss Medical Weekly (April 21, 2007): Vol. 137, No. 15–16, pp. 215–16. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17525875
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »